Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial.

Ilana GraetzCaitlin N McKillopEdward StepanskiGregory A VidalJaneane N AndersonLee S Schwartzberg

Published in: Journal of cancer survivorship : research and practice (2018)

If short-term gains in adherence persist, this low-cost intervention could improve survival outcomes for women with breast cancer. A larger, long-term study should examine if AI adherence and symptom burden improvements persist for a 5-year treatment period.

Keyphrases

low cost
glycemic control
study protocol
patient reported
phase iii
risk factors
adipose tissue
phase ii
machine learning
deep learning
smoking cessation
replacement therapy